For patients managing chronic conditions like allergies or migraines, the recurring cost of over-the-counter medications and supplements is a quiet, persistent burden. Onfy, a Berlin-based marketplace founded in 2021, bets a B2B2C model can cut those costs. It connects pharmacies and consumers directly to manufacturers [Onfy.de].
The company claims over 70,000 prescription-free health products priced 20 to 60 percent below recommended retail on average. Discounts reach 75 percent sometimes [TechCrunch].
Founder and CEO Iana Liaskovik aims to disintermediate wholesalers. Pharmacies source vitamins, nasal sprays, skincare directly. Savings pass to consumers. Independents compete with online giants [Onfy.de].
Onfy embeds Banxware financing for pharmacy credit lines [Banxware.com]. This offers two-sided value: cheaper goods, better cash flow.
German patients choose local Apotheke for service, higher prices. Or Shop Apotheke, DocMorris for convenience, discounts.
Onfy sits between. Bulk price advantage, partner fulfillment, compliance.
Path forward unproven. Needs dense pharmacy network, structural prices.
Traction limited to 83,664 items per one site [Medizinfuchs.de]. Crowded field competes for health spend.
Banxware integration signals execution beyond listings. Prove volume for partners, revenue stability.
Test: do savings change buying habits?